Rockefeller Capital Management L.P. Raises Holdings in CME Group Inc. $CME

Posted by George Bondi on Jun 22nd, 2026

Rockefeller Capital Management L.P. increased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 16.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 156,976 shares of the financial services provider’s stock after purchasing an additional 22,286 shares during the period. Rockefeller Capital Management L.P.’s holdings in CME Group were worth $42,867,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after buying an additional 588,509 shares during the last quarter. State Street Corp lifted its stake in CME Group by 0.4% in the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after buying an additional 56,725 shares during the last quarter. Norges Bank acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $1,523,241,000. Bank of New York Mellon Corp grew its position in shares of CME Group by 2.8% during the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after acquiring an additional 134,242 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after acquiring an additional 130,848 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

More CME Group News

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Activity

In related news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Barclays reduced their price target on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research report on Thursday, April 23rd. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Morgan Stanley dropped their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research note on Thursday, April 23rd. Raymond James Financial upped their target price on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Finally, TD Cowen decreased their target price on shares of CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Twelve research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, CME Group has a consensus rating of “Moderate Buy” and an average price target of $305.18.

Check Out Our Latest Research Report on CME Group

CME Group Stock Performance

Shares of CME opened at $246.38 on Monday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market capitalization of $89.28 billion, a P/E ratio of 21.02, a P/E/G ratio of 2.75 and a beta of 0.21. The company’s fifty day moving average is $279.61 and its two-hundred day moving average is $287.27. CME Group Inc. has a 1 year low of $244.56 and a 1 year high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the firm earned $2.80 EPS. CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts predict that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.